bioreference patient portal login

Why choose BioReference for prostate cancer diagnostics?

If you are experiencing patient portal issues related to identity verification or login, please call us at 1-888-279-0967 M-F 8AM-8PM ET and Sa-Su 9AM-5PM ET or send an email to patientportal@bioreference.com with your name and phone number, and we will get back to you as soon as possible.

How do I view my BioReference test results?

patient-portal. Published May 26, 2021 at 1800 × 300 in patient-portal.

How do I make sure I am receiving patient portal emails?

Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec. 10, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that it is providing BioReference Laboratories, Inc., an OPKO Health company and a leading provider of laboratory testing …

What is patient portal?

Posted on March 31, 2021 September 10, 2021 by Erika Erdmann. SPOKANE, Wash., March 30, 2021 /PRNewswire/ — Gestalt Diagnostics today announced, that BioReference Laboratories Inc., an OPKO Health company, has selected their digital pathology solution, PathFlow®, to support its pathology business. PathFlow is an enterprise software platform ...

BioReference Celebrates 40 Years: Our Story

This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution.

Auth0 and BioReference Laboratories Answer Patient Demand for Secure, Direct Access to Test Results

Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec.

Gynecological Cancer Awareness Month

Gynecologic Cancer Awareness Month is an opportunity to raise awareness of the different types of cancers that originate in a woman’s reproductive organs.Each year, about 94,000 women are diagnosed with gynecologic cancer so it is important to understand the risk factors and possible symptoms along with available treatment options.

In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1

Updated Cancer Risk Estimates Will Allow For More Personalized Risk Assessment and Informed Decision Making For Patients with Rare Form of Hereditary Stomach Cancer GAITHERSBURG, Md., Aug.

The laboratory at your fingertips

BioReference is empowering patients with knowledge to enhance engagement in their healthcare journey through digitally enabled, secure, and on-demand solutions.

COVID-19 Game Plan

The days are getting shorter, there is a cool crisp in the air, and the leaves are changing colors; it’s undoubtedly fall. The return of the autumnal season also means football has kicked-off, baseball playoffs are here, basketball is just beginning, hockey players are ready to hit the ice, and soccer teams have rivalry match-ups.

NBA to primarily use rapid tests for COVID-19 in 2021-22

Given the league’s high vaccination rate, the NBA’s primary form of COVID-19 detection this season will center on designated team officials — largely members of the medical staff — using small, at-home, molecular-based testing devices that can return results in 20 minutes.